Trials / Completed
CompletedNCT05017415
Applicability of Uroflowmetry in Children with Cerebral Palsy
What is the Difference in the Applicability of the Uroflowmetry Between Children with Cerebral Palsy (CP) with Lower Urinary Tract Symptoms (LUTS) and Without Lower Urinary Tract Symptoms (LUTS)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 56 (actual)
- Sponsor
- University Hospital, Ghent · Academic / Other
- Sex
- All
- Age
- 5 Years – 12 Years
- Healthy volunteers
- Not accepted
Summary
Until now, the use of invasive urodynamics with use of catheters is still the gold standard for lower urinary tract evaluation in subjects with CP. This suggests a psychological and physical impact of invasive urodynamics in subjects with CP and further demonstrates the need to avoid standard use of invasive urodynamics in children and adults with CP. The current study will evaluate usefulness of uroflowmetry, correlation between uroflowmetry parameters and different lower urinary tract symptoms will be investigated. Secondly, results of uroflowmetry indicating possible vulnerability of the upper urinary tract will be defined.
Detailed description
A cross-sectional case-control study comparing children with CP and LUTS and children with CP without LUTS will be conducted with the primary objective to investigate correlation between uroflowmetry parameters and different LUTS. Children will be evaluated with uroflowmetry and subsequent post void residual measurement and the validated vancouver symptom score for dysfunctional elimination syndrome.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | uroflow measurement | Non-invasive urodynamic measurement wireless uroflowmeter UROCAP™ IV, Goby System Laborie |
| DEVICE | Bladder ultrasound | Ultrasound of post void residual urine bladderscan CUBEscan BioCon 700 |
Timeline
- Start date
- 2021-10-14
- Primary completion
- 2023-06-30
- Completion
- 2023-06-30
- First posted
- 2021-08-23
- Last updated
- 2024-09-19
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT05017415. Inclusion in this directory is not an endorsement.